Skip to main content
Production in Australia)



CSL Seqirus markets and distributes a number of vaccines and pharmaceutical products to ensure a comprehensive range of products are available to the New Zealand market.

Information on our products is intended for use by New Zealanders:
  • Healthcare professionals who want to know more about a CSL Seqirus product,
  • and individuals who have been prescribed a CSL Seqirus product


In-Licensed Products

BCG VACCINE AJV™ is a trademark of AJ Vaccines A/S.
DUKORAL® and JESPECT® are registered trademarks of Valneva Sweden AB.
GARDASIL® 9 is a registered trademark of Merck & Co. Inc Whitehouse Station, NJ, USA.
RABIPUR® is a registered trademark of Bavarian Nordic A/S.
TRAMAL® is a registered trademark of Grunenthal GmbH used by Seqirus as authorised user.
VIMPAT® is a registered trademark used by UCB Pharma GmbH under license.
All other trademarks are registered by Seqirus UK Limited or its affiliates in one or more jurisdictions.

Pandemic Response Solutions

As a global leader in influenza vaccine manufacturing, CSL Seqirus offers a portfolio of pandemic vaccines and services which are tailored to rapid response.
Learn more




CSL privacy statement
CSL privacy statement

This website contains content which is for New Zealand healthcare professionals only. By selecting this box you acknowledge that you are a new Zealand healthcare professional and accessing this website within the scope of your daily practice.